KR100616029B1 - 아릴 에테르의 제조 방법 - Google Patents

아릴 에테르의 제조 방법 Download PDF

Info

Publication number
KR100616029B1
KR100616029B1 KR1020067014909A KR20067014909A KR100616029B1 KR 100616029 B1 KR100616029 B1 KR 100616029B1 KR 1020067014909 A KR1020067014909 A KR 1020067014909A KR 20067014909 A KR20067014909 A KR 20067014909A KR 100616029 B1 KR100616029 B1 KR 100616029B1
Authority
KR
South Korea
Prior art keywords
formula
reaction
carried out
compound
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020067014909A
Other languages
English (en)
Korean (ko)
Other versions
KR20060090310A (ko
Inventor
케빈 이. 헤네가
사라 엘리자베스 만치니
키이스 더글라스 마이스토
Original Assignee
파마시아 앤드 업존 캄파니 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 파마시아 앤드 업존 캄파니 엘엘씨 filed Critical 파마시아 앤드 업존 캄파니 엘엘씨
Publication of KR20060090310A publication Critical patent/KR20060090310A/ko
Application granted granted Critical
Publication of KR100616029B1 publication Critical patent/KR100616029B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/04—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D301/00—Preparation of oxiranes
    • C07D301/02—Synthesis of the oxirane ring
    • C07D301/03—Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds
    • C07D301/14—Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds with organic peracids, or salts, anhydrides or esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/14—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by free hydroxyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020067014909A 1998-12-29 1999-12-23 아릴 에테르의 제조 방법 Expired - Fee Related KR100616029B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11409298P 1998-12-29 1998-12-29
US60/114,092 1998-12-29

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020017008269A Division KR100616386B1 (ko) 1998-12-29 1999-12-23 아릴 에테르의 제조 방법

Publications (2)

Publication Number Publication Date
KR20060090310A KR20060090310A (ko) 2006-08-10
KR100616029B1 true KR100616029B1 (ko) 2006-08-28

Family

ID=22353332

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020017008269A Expired - Fee Related KR100616386B1 (ko) 1998-12-29 1999-12-23 아릴 에테르의 제조 방법
KR1020067014909A Expired - Fee Related KR100616029B1 (ko) 1998-12-29 1999-12-23 아릴 에테르의 제조 방법

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1020017008269A Expired - Fee Related KR100616386B1 (ko) 1998-12-29 1999-12-23 아릴 에테르의 제조 방법

Country Status (24)

Country Link
US (1) US6376711B1 (enExample)
EP (2) EP1308443B1 (enExample)
JP (1) JP2002533430A (enExample)
KR (2) KR100616386B1 (enExample)
CN (3) CN1249038C (enExample)
AT (2) ATE260238T1 (enExample)
AU (1) AU764492B2 (enExample)
BR (1) BR9916615A (enExample)
CA (1) CA2349619A1 (enExample)
CO (1) CO5140125A1 (enExample)
DE (2) DE69940833D1 (enExample)
DK (1) DK1140788T3 (enExample)
ES (1) ES2214060T3 (enExample)
HK (1) HK1041688B (enExample)
HU (1) HUP0202144A3 (enExample)
IL (2) IL161840A0 (enExample)
NZ (1) NZ511452A (enExample)
PE (1) PE20001366A1 (enExample)
PT (1) PT1140788E (enExample)
SI (1) SI1140788T1 (enExample)
TR (1) TR200101885T2 (enExample)
TW (1) TWI238155B (enExample)
WO (1) WO2000039072A1 (enExample)
ZA (1) ZA200103532B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796069B3 (fr) 1999-07-09 2001-08-24 Sanofi Synthelabo Nouveaux procedes de preparation de derives de 2-(2- arylmorpholin-2-yl)ethanol substitues, enantiomeriquement purs, et composes intermediaires utiles dans ces procedes
AR030284A1 (es) * 2000-06-08 2003-08-20 Merck & Co Inc Proceso para la sintesis de (2r, 2-alfa-r,3a) -2-[1-(3,5-bis(trifluorometil) fenil) etoxi]-3-(4-fluorofenil)-1,4-oxazina; dicho compuesto y sus formas polimorficas
BRPI0507917A (pt) * 2004-02-20 2007-07-10 Pharmacia & Upjohn Co Llc método para preparação de éteres de arila
WO2005082869A1 (en) * 2004-02-20 2005-09-09 Pharmacia & Upjohn Company Llc Method for the preparation of aryl ethers
WO2005095435A1 (ja) * 2004-03-31 2005-10-13 Kuraray Co., Ltd. プレグナン誘導体の製造方法
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
EA200601798A1 (ru) 2004-04-30 2007-04-27 Уорнер-Ламберт Компани Ллс Замещенные соединения морфолина для лечения расстройств центральной нервной системы
SI2076508T1 (sl) 2006-10-18 2011-04-29 Pfizer Prod Inc Spojine biaril eter sečnine
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine
CN103804316A (zh) * 2012-11-13 2014-05-21 天津药物研究院 一种（2RS,3RS）-6-[a-（2-乙氧基苯氧基）苄基]吗啉-3-酮（Ⅰ）的制备方法
CN104557936A (zh) * 2015-01-15 2015-04-29 河南科技学院 一种新型手性非环嘌呤核苷类似物的合成方法
US20190381056A1 (en) 2018-06-17 2019-12-19 Axsome Therapeutics, Inc. Compositions for delivery of reboxetine
US20200147093A1 (en) 2018-10-15 2020-05-14 Axsome Therapeutics, Inc. Use of esreboxetine to treat nervous system disorders such as fibromyalgia
US11020402B2 (en) 2018-10-15 2021-06-01 Axsome Therapeutics, Inc. Use of reboxetine to treat narcolepsy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2785185A (en) * 1952-08-07 1957-03-12 Union Carbide & Carbon Corp Process for making oxirane compounds from olefins and aldehyde monoperacylates
GB1053972A (enExample) * 1962-08-30 1967-01-04
IL56369A (en) * 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
GB8419683D0 (en) * 1984-08-02 1984-09-05 Erba Farmitalia 3-substituted derivatives of 1-amino-2-hydroxy-propane

Also Published As

Publication number Publication date
EP1140788A1 (en) 2001-10-10
ATE430144T1 (de) 2009-05-15
CA2349619A1 (en) 2000-07-06
ZA200103532B (en) 2002-08-02
ES2214060T3 (es) 2004-09-01
CN1332719A (zh) 2002-01-23
TR200101885T2 (tr) 2002-01-21
DE69915110D1 (de) 2004-04-01
DK1140788T3 (da) 2004-06-07
ATE260238T1 (de) 2004-03-15
SI1140788T1 (en) 2004-08-31
CN1308332C (zh) 2007-04-04
IL144012A (en) 2005-11-20
CN1636988A (zh) 2005-07-13
DE69915110T2 (de) 2004-08-26
HK1078572A1 (zh) 2006-03-17
EP1308443A2 (en) 2003-05-07
HUP0202144A2 (hu) 2002-11-28
EP1308443B1 (en) 2009-04-29
EP1140788B1 (en) 2004-02-25
US6376711B1 (en) 2002-04-23
EP1308443A3 (en) 2003-10-01
JP2002533430A (ja) 2002-10-08
HK1041688A1 (en) 2002-07-19
IL161840A0 (en) 2005-11-20
AU2381900A (en) 2000-07-31
PE20001366A1 (es) 2000-11-19
KR20060090310A (ko) 2006-08-10
PT1140788E (pt) 2004-07-30
HK1041688B (zh) 2007-12-07
KR20010099999A (ko) 2001-11-09
NZ511452A (en) 2002-11-26
BR9916615A (pt) 2001-10-23
HUP0202144A3 (en) 2003-10-28
TWI238155B (en) 2005-08-21
CN100340552C (zh) 2007-10-03
CO5140125A1 (es) 2002-03-22
CN1532194A (zh) 2004-09-29
CN1249038C (zh) 2006-04-05
AU764492B2 (en) 2003-08-21
IL144012A0 (en) 2002-04-21
KR100616386B1 (ko) 2006-08-28
WO2000039072A1 (en) 2000-07-06
HK1066004A1 (en) 2005-03-11
DE69940833D1 (de) 2009-06-10

Similar Documents

Publication Publication Date Title
KR100616029B1 (ko) 아릴 에테르의 제조 방법
Bravo et al. New fluorinated chiral synthons
EP1840125B1 (fr) Intermédiaires pour la production de dioxane-2-alkylcarbamates
NO172846B (no) Fremgangsmaate for fremstilling av 7,8-dihalogen-3-metyl-2,3-dihydro-2m-benzoksazinderivater og propoksybenzenderivater for utoevelse av fremgangsmaaten.
US6278002B1 (en) Process for the preparation of (2r,3s)-3-amino-1,2-oxirane
GB1594450A (en) 1,3-oxathiolane sulphoxides and their use in the preparation of 5,6-dihydro-2-methyl-1,4-oxathiin derivatives
US4395561A (en) Synthesis of 3-hydroxyoxetane
Machinaga et al. Improved Syntheses of Both Enantiomers of 1, 2, 5, 6-Diepoxyhexane from (2S, 5S)-1, 2, 5, 6-Hexanetetrol
CA2882694C (en) Processes for preparing morphine compounds
KR100315836B1 (ko) 부틸티오-이소퀴놀린의 제조방법 및 이를 위한 중간체
MXPA01006680A (en) Method for the preparation of aryl ethers
JP2000219669A (ja) アルコールのスルホニル化方法
US7265232B2 (en) Process for producing glycidyl ether
Yu et al. A new and efficient route to derivatives of (R)-4-hydroxycyclohex-2-enone
최홍대 et al. Synthesis of 2-Phenylbenzo [b] furan Derivatives Using 2-Chloro-2-(methylthio) acetophenone
HK1078572B (en) Method for the preparation of aryl ethers
CA2430302A1 (fr) Procede de cyclisation pour la synthese de composes derives de pyrrolidine
HK1066004B (en) Method for the preparation of aryl ethers
EP0383613A2 (en) Optically active lactate, derivatives thereof and processes of producing same
JP2008100951A (ja) ２−シクロペンタデセノンの製造方法
JPH10310580A (ja) クラウンｃ６０錯体およびその製造法

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A16-div-PA0104

St.27 status event code: A-0-1-A10-A18-div-PA0104

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

Fee payment year number: 1

St.27 status event code: A-2-2-U10-U12-oth-PR1002

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

Not in force date: 20090819

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

St.27 status event code: A-4-4-U10-U13-oth-PC1903

PC1903 Unpaid annual fee

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20090819

St.27 status event code: N-4-6-H10-H13-oth-PC1903

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000